SARS-CoV-2-triggered lymphocytic colitis

5Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

The ability of SARS-CoV-2 to infect the gastrointestinal tract is well described. Inflammatory bowel diseases (IBD) are believed to represent a disorganised immune response in genetically predisposed individuals, which are triggered by various environmental factors, notably infections. Here we report a case of chronic watery diarrhoea that was triggered by a SARS-CoV-2 infection. The work-up confirmed a new diagnosis of lymphocytic colitis, and the patient responded favourably to a course of oral budesonide. Clinicians should become vigilant to the possibility of triggered IBD in patients with persistent diarrhoea following a SARS-CoV-2 infection.

Cite

CITATION STYLE

APA

Nassar, I. O., Langman, G., Quraishi, M. N., & Sharma, N. (2021). SARS-CoV-2-triggered lymphocytic colitis. BMJ Case Reports , 14(8). https://doi.org/10.1136/bcr-2021-243003

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free